Use of antacids, alginates and proton pump inhibitors: a survey of the general Danish population using an internet panel
Authors:
- Christina ReimerCRChristina Reimer
- Peter BytzerPBPeter Bytzer
- 22 May 2014
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 49 (9) , 1044-1050
Abstract
Both over-the-counter medicine, such as antacids or alginates, and proton pump inhibitors (PPI) are used for treating acid-related disorders. We sought to describe what characterizes users of these different medicines, including long-term PPI users within the general population. A cross-sectional survey was conducted in an internet panel representative of the Danish adult population in 2012. Data queried included antacid/alginate and PPI use, reason for therapy, co-medication, and presence of upper gastrointestinal symptoms. Long-term PPI use was defined as using PPI ≥1/3 of the last year (∼120 days). Risk of long-term PPI use was estimated by logistic regression. A total of 18,223 people received the questionnaire, of which 52% (9390) responded. Antacid/alginate use was reported by 23%; 16% reported use of only antacid/alginate. PPI use was reported by 13.6%; 6.2% were defined as long-term PPI users. Antacid/alginate users were younger, used less co-medication, had most often started on therapy because of reflux symptoms, and had less often ongoing symptoms. Risk of long-term PPI use appeared to be increased in male gender, by renewing PPI prescription by phone/e-mail, using co-medication, and having started on PPI for several reasons. Combination of antacid/alginate and PPI was reported by approximately 50% of those on therapy with weekly or daily symptoms. 23% of Danish adults were using antacids or alginates and 14% were using PPI, of which one-half were on long-term therapy. Prescription renewal by phone or e-mail and use of other prescription medication were associated with long-term PPI use, indicating a behavioral pattern, in which unnecessary PPI therapy may be maintained.Keywords
This publication has 20 references indexed in Scilit:
- Systematic Review: Patterns of Proton Pump Inhibitor Use and Adherence in Gastroesophageal Reflux DiseaseClinical Gastroenterology and Hepatology, 2012
- Efficacy of adding sodium alginate to omeprazole in patients with nonerosive reflux disease: a randomized clinical trialDiseases of the Esophagus, 2011
- Evidence That Proton-Pump Inhibitor Therapy Induces the Symptoms it Is Used to TreatGastroenterology, 2009
- Treatment patterns and symptom control in patients with GERD: US community-based surveyCurrent Medical Research and Opinion, 2009
- Symptoms in patients on long‐term proton pump inhibitors: prevalence and predictorsAlimentary Pharmacology & Therapeutics, 2009
- American Gastroenterological Association Institute Technical Review on the Management of Gastroesophageal Reflux DiseaseGastroenterology, 2008
- Persistence and adherence to proton pump inhibitors in daily clinical practiceAlimentary Pharmacology & Therapeutics, 2006
- Review article: the long‐term use of proton‐pump inhibitorsAlimentary Pharmacology & Therapeutics, 2005
- Use of anti-secretory medication: a population-based cohort studyAlimentary Pharmacology & Therapeutics, 2004
- Use of Antacids in a General Population: The Impact of Health-Related Variables, Lifestyle and Sociodemographic CharacteristicsJournal of Clinical Epidemiology, 1999